Experimental and Molecular Medicine Impact Factor: What Researchers Need to Know
That moment when you're scrolling through faculty evaluation criteria or deciding where to submit your latest research, and you see "experimental and molecular medicine impact factor" pop up again. On the flip side, maybe you've seen it mentioned in journal comparison tools, or a colleague referenced it in conversation. And you realized you probably should know more about it than you currently do.
You're not alone. Most researchers have a working understanding of impact factors, but the specifics around individual journals — especially specialized ones like Experimental & Molecular Medicine* (EMM) — often stay fuzzy until you actually need them.
Here's the thing — understanding a journal's impact factor isn't just about vanity metrics or where something sits on a ranking list. It's about understanding the reach and influence of the work you're engaging with, whether you're publishing, reviewing, or simply keeping up with the literature.
Let's dig into what the impact factor for Experimental & Molecular Medicine* actually means, how it stacks up, and what you should actually care about when evaluating this journal.
What Is Experimental & Molecular Medicine?
Experimental & Molecular Medicine* is a peer-reviewed scientific journal that focuses on publishes research at the intersection of experimental approaches and molecular medicine. The journal covers a broad range of topics, including but not limited to cancer biology, immunology, genetics, stem cell research, and molecular therapeutics.
It's the official journal of the Korean Society for Molecular Biology, and it's been around since 1964 — making it one of the more established journals in its space. The journal operates under Nature Publishing Group's umbrella, which gives it some serious infrastructure and global distribution.
What sets EMM apart is its commitment to publishing work that bridges basic science and clinical application. You won't just find isolated molecular findings here. The journal has a track record of prioritizing research with translational relevance — work that takes molecular insights and moves them closer to clinical reality.
The Scope in Practice
If you're working in molecular oncology, immunotherapy, gene editing technologies, or precision medicine, EMM is likely on your radar. Also, the journal publishes original research articles, reviews, and perspectives. It also handles rapid communications for time-sensitive findings.
The editorial board pulls in researchers from institutions across Asia, North America, and Europe, which means the journal maintains a genuinely international perspective rather than operating within a single regional bubble.
Why the Experimental and Molecular Medicine Impact Factor Matters
Impact factor gets talked about constantly in academic circles, but let's make sure we're on the same page about what it actually measures — and what it doesn't.
Impact factor is a metric calculated by Clarivate (formerly part of Thomson Reuters) that represents the average number of citations received by articles published in a journal over the previous two years. So when someone says a journal has an impact factor of 8, they're saying that articles published in that journal received, on average, 8 citations each in the year following publication.
For Experimental & Molecular Medicine*, the impact factor has shown meaningful growth over the past several years, climbing into the 5-6 range and holding steady in reputable territory for its field. This isn't a vanity journal — it's one that actually gets read and cited by other researchers doing real work.
Why This Should Matter to You
Here's where it gets practical. The impact factor matters in a few concrete ways:
For job seekers and faculty candidates: Institutions often use journal impact factors as a quick proxy for research quality during hiring and promotion decisions. A publication in a higher-impact journal signals broader visibility and citation potential.
For grant applicants: Funding agencies frequently consider publication record, including where work appears. A strong journal portfolio strengthens an application.
For collaborations: Researchers often check journal impact factors when considering collaboration opportunities or evaluating whether to engage with certain published work.
But — and this is important — impact factor is one signal among many. A high impact factor doesn't automatically mean your specific paper will get lots of citations. A lower impact factor in a highly specialized niche might reach exactly the right audience for your work.
What Impact Factor Doesn't Tell You
This is where a lot of people get tripped up. Still, impact factor measures citation frequency, not article quality. A well-cited but methodologically flawed paper can boost a journal's impact factor just as easily as impactful research.
EMM's impact factor reflects the journal's overall performance, but individual articles vary widely. A well-designed study in a niche area might accumulate few citations simply because fewer researchers are working in that space — not because the work is less important.
How the Journal Is Positioned in Its Field
Within the landscape of molecular medicine journals, Experimental & Molecular Medicine* occupies a middle-to-upper tier position. It's not competing with the absolute top-tier general science journals, but it's well above average for specialized publications in the field.
Want to learn more? We recommend crystal growth & design impact factor and what is pencil lead made of for further reading.
Ranking Context
When you look at where EMM sits among journals in the "Medicine" and "Biochemistry & Molecular Biology" categories in Journal Citation Reports, it performs solidly. The climb in impact factor over recent years reflects both increased submission quality and better visibility through Nature Publishing Group's distribution channels.
For researchers deciding where to submit, this positioning matters. EMM is ambitious enough to be worth listing on your CV, but realistic enough that it's an achievable target for strong work that might not make the cut at top-tier generalist journals.
The Open Access Question
EMM operates on a hybrid model — some articles are open access, others are subscription-only. This gives authors flexibility depending on their funding and dissemination goals. The journal follows standard Nature Publishing Group policies, including clear data availability statements and author guidelines.
If open access is a requirement for your funder (and increasingly, it is), you'll want to check the current open access options and associated article processing charges before submitting.
Common Misconceptions About Impact Factor
Most researchers have absorbed impact factor lore through informal channels — lab gossip, department politics, and occasionally outdated institutional guidelines. Here's what people often get wrong:
"Higher impact factor always means better research"
Not true. Practically speaking, citation counts are influenced by field size, topic popularity, and even article type. Plus, a review article will naturally accumulate more citations than an original research article. A paper on a trendy topic will outperform a timeless but less fashionable one. Impact factor measures visibility, not rigor.
If you take away one thing from this section, make it this.
"If it's not in a high-impact journal, no one will read it"
Wrong again. Many specialized journals have dedicated readerships who actively follow the literature in their niche. EMM reaches researchers who care deeply about molecular medicine applications — arguably more valuable than reaching a general audience who might skim your abstract and move on.
"Impact factor is the only metric that matters"
Plenty of other metrics exist: h-index (for individual researchers),CiteScore, SCImago Journal Rank, and altmetrics for broader impact. Journal metrics should be one input in your decision-making, not the entire equation.
What Actually Works: Practical Guidance for Using This Information
So what should you actually do with all this information? Here's some honest advice:
Use impact factor as a starting point, not a destination. Before submitting anywhere, read recent articles from the journal. Does your work fit the editorial scope? Does the journal publish the article types you're producing? Does the writing style and presentation match what you're aiming for?
Match your ambition to the journal. If your work is genuinely novel and comprehensive, aim higher. If it's solid but incremental, a journal like EMM might be exactly right. Forcing work into the wrong tier — too high or too low —
typically ends in frustration for everyone involved.
Think about your audience. Who do you actually want reading this paper? Clinicians in your subspecialty? Basic researchers in your exact niche? Graduate students exploring new methods? Different journals serve different communities, and finding the right match matters more than chasing a number.
Consider the editorial timeline. High-impact journals often have review processes that stretch six months to a year or more, with desk rejections at rates exceeding 80%. Specialty journals like EMM often provide faster, more constructive feedback from editors who genuinely understand the work. If timely dissemination matters, this is worth weighing.
A Final Thought
Experimental & Molecular Medicine has built its reputation by serving a specific community well rather than trying to be everything to everyone. Also, its impact factor reflects sustained quality and consistent citation within its field. Whether that makes it the right home for your next paper depends entirely on what that paper is, who needs to read it, and what you're trying to accomplish.
The best journal for your work isn't necessarily the one with the highest number attached to its name. It's the one where your research will find its intended audience, receive fair evaluation, and contribute meaningfully to ongoing scientific conversation. Sometimes it's a specialized publication like EMM. Sometimes that's a Nature-family journal. The skill lies in knowing which is which — and having the confidence to choose based on substance rather than prestige.
Numbers tell part of the story. They never tell the whole story.
